Hera BioLabs and the Future of Precision Preclinical Research
In the long, uncertain journey from laboratory discovery to approved medicine, the preclinical phase is where ambition first meets biological reality. It is the stage at which hypotheses are tested against living systems, safety signals emerge, and countless drug candidates quietly fail. For decades, the industry has relied on familiar animal models and gene-editing techniques…
